Figure 2From: Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker Western blot analysis of ORM2, CD14, BTD and GPX3. (A) Western blot analysis was performed for the plasmas of 6 breast cancer patients and age-matched 6 normal healthy women that had been previously used for ICAT experiment. (B) Western blot images were quantified by densitometric scanning and plotted. Lines denote the average of intensity values.Back to article page